| Summary: | "It is with great enthusiasm that we introduce the second edition of Pocket Oncology. The first edition was well received, and given many exciting new developments in the oncology, we are now eager to release an updated second edition. Several new sections have been added to this updated edition, including information on chimeric antigen receptor (CAR) T-cell therapy, immunotherapy toxicity, and novel oral anticoagulants. We have additionally incorporated more information about precision targeted therapeutic strategies. Each disease section has been updated to reflect cancer care in 2017"--Provided by publisher.
|
|---|
